HealthTree Logo
search more_vert
person Sign In / Create Account
Austin Myeloma Round Table
Austin Myeloma Round Table image
HealthTree Roundtables for Multiple Myeloma

Event Description



Why Stem Cells Matter - William Matsui, MD | MRT Austin, TX Mar 25, 2023


So Many Choices: Deciding Which Treatment is Best - Matthew Butler, MD | MRT Austin, TX Mar 25, 2023


Moving Novel Concepts Toward Front-Line Treatments - Hans Lee, MD | MRT Austin, TX Mar 25, 2023


Syed Abbas Ali Presents Case Studies: Discussion with Morning Faculty | MRT Austin, TX Mar 25, 2023


Round Table Audience Q&A Session One | MRT Austin, TX Mar 25, 2023


Extending Remission - Syed Abbas Ali, MBBS | MRT Austin, TX Mar 25, 2023


Full Faculty Group Discussion | MRT Austin, TX Mar 25, 2023


Why Stem Cells Matter - William Matsui, MD | MRT Austin, TX Mar 25, 2023


Round Table Audience Q&A Two | MRT Austin, TX Mar 25, 2023


Speakers & Moderators

The panelist William Matsui, MD
William Matsui, MD

William Matsui, MD, is Deputy Director of the LIVESTRONG Cancer Institutes, Professor in the Department Oncology and Director of Hematological Malignancies Program at the Dell Medical School at the University of Texas at Austin. He specializes in caring for patients with cancers that involve the blood and bone marrow as well as bone marrow transplantation. He came to Austin from the Johns Hopkins University School of Medicine, where he was a professor of oncology and served as the director of the Multiple Myeloma Program and the co-director of the Division of Hematologic Malignancies. Dr. Matsui has carried out laboratory-based translational research throughout his career and focused on studying cancer stem cells, tumor cells with enhanced growth potential and their role in clinical oncology. His laboratory first identified cancer stem cells in the plasma cell malignancy multiple myeloma in 2003 and subsequently in other cancers including lymphomas, leukemias and pancreas cancer. His laboratory has also demonstrated that several pathways regulating normal stem cells, including those involved in embryonic development, are abnormally activated in cancer stem cells. Dr. Matsui completed his residency training in internal medicine at the University of Washington in Seattle and his clinical training in medical oncology at Johns Hopkins. He earned his medical degree from the University of California at San Francisco.

Read Bio
The panelist Hans Lee, MD
Hans Lee, MD

Hans Lee, MD, is Assistant Professor in the Department of Lymphoma/Myeloma and Director of Multiple Myeloma Clinical Research at the MD Anderson Cancer Center in Houston, TX. Previously, Dr. Lee was the Chief Hematology Fellow at MD Anderson, where he previously held a Clinical Fellowship. He was a resident in Internal Medicine at the Washington University School of Medicine in St. Louis, MO after he earned his MD at the Indiana School of Medicine in Indianapolis, IN.

Read Bio
The panelist Syed Abbas Ali, MBBS
Syed Abbas Ali, MBBS

Dr. Syed Abbas Ali is a medical oncology specialist in Baltimore, caring for patients with cancer. Dr. Ali earned his M.B.B.S. at The Aga Khan University. He completed his residency at the University of Arkansas for Medical Sciences and performed a fellowship in medical oncology at the National Institutes of Health.

Read Bio
The panelist Matthew Butler
Matthew Butler

Dr. Matthew Butler is a faculty member of the division of hematology and oncology. Dr. Butler grew up in Nova Scotia, Canada, and worked in Toronto as a software developer before starting medical school. He completed his specialty training at UT Health San Antonio with a focus on blood cancers. His practice covers the full range of blood disorders, with a special interest in multiple myeloma. His clinical research focus is aimed at finding better treatments for malignant lymphomas

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Bristol Myers Squibb

Follow Us

facebook twitter